Faizan Mazhar

A Unit of Clinical Pharmacology, Department of Biomedical and Clinical Sciences L. Sacco, “Luigi Sacco” University Hospital, Università Di Milano, Milan, Italy, Italy

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Poster(s):

• (P-171) Adverse Events Associated with Remdesivir in covid-19 Patients: Evaluation of Spontaneous Reports Submitted to US FDA Adverse Event Reporting System (FAERS)

• (P-172) Tocilizumab Induced Adverse Events in covid-19 Patients: Exploration of Reports Submitted to US FDA Adverse Event Reporting System (FAERS)

• (P-173) Adverse Events in covid-19 Patients Treated with Lopinavir/ritonavir: Exploration of US FDA Adverse Event Reporting System (FAERS) Reports